Abstract
Nephrotoxicity was assessed in 173 critically ill patients receiving intravenous colistin or polymyxin B; it occurred in 60.4% and 41.8%, respectively. Further investigation is necessary to elucidate the reason for the difference in nephrotoxicity observed between the groups and to assess the impact of severity of illness and dosing/administration.
Keywords:
AKI; PB; colistimethate sodium; colistin; nephrotoxicity.
MeSH terms
-
Acute Kidney Injury / chemically induced*
-
Acute Kidney Injury / epidemiology*
-
Administration, Intravenous
-
Adult
-
Aged
-
Aged, 80 and over
-
Anti-Bacterial Agents / administration & dosage
-
Anti-Bacterial Agents / adverse effects*
-
Cohort Studies
-
Colistin / administration & dosage
-
Colistin / adverse effects
-
Colistin / analogs & derivatives*
-
Critical Illness
-
Female
-
Humans
-
Incidence
-
Male
-
Middle Aged
-
Polymyxin B / administration & dosage
-
Polymyxin B / adverse effects*
-
Retrospective Studies
-
Tertiary Care Centers
Substances
-
Anti-Bacterial Agents
-
colistinmethanesulfonic acid
-
Polymyxin B
-
Colistin